HFCAS OpenIR

浏览/检索结果: 共1条,第1-1条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
A randomized, controlled, multi-center, open-label study of adjuvant nab-paclitaxel plus S-1 (AS) versus capecitabine plus oxaliplatin (CapeOX) for stage III gastric cancer after D2 resection. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yu, Pengfei;  Du, Yian;  Xu, Zhiyuan;  Yang, Litao;  Ying, Jieer;  Wang, Yongxiang;  Chen, Ping;  Wei, Yunhai;  Xu, Hongtao;  Xu, Nong;  Cheng, Xiangdong
收藏  |  浏览/下载:47/0  |  提交时间:2022/12/23